Cargando…
Use of inflammatory molecules to predict the occurrence of fever in onco-hematological patients with neutropenia
Febrile neutropenia remains a frequent complication in onco-hematological patients, and changes in the circulating level of inflammatory molecules (IM) may precede the occurrence of fever. The present observational prospective study was carried out to evaluate the behavior of plasma tumor necrosis f...
Autores principales: | Ribeiro, A.F. Tibúrcio, Nobre, V., Neuenschwander, L.C., Teixeira, A.L., Xavier, S.G., Paula, F.D.F., Teixeira, M.M., Teixeira, J.C.A., Bittencourt, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854365/ https://www.ncbi.nlm.nih.gov/pubmed/23369970 http://dx.doi.org/10.1590/1414-431X20122397 |
Ejemplares similares
-
Plasma levels of procalcitonin and eight additional inflammatory molecules in febrile neutropenic patients
por: Neuenschwander, Letícia Carvalho, et al.
Publicado: (2011) -
Sepsis and neutropenia in hematological malignancies
por: Labiad, Y, et al.
Publicado: (2014) -
Safety of switching between rituximab biosimilars in onco-hematology
por: Urru, Silvana A. M., et al.
Publicado: (2021) -
Surgical Management of Rhinosinusitis in Onco-Hematological Patients
por: Di Girolamo, Stefano, et al.
Publicado: (2014) -
Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients.
por: Marzano, Alfredo, et al.
Publicado: (2010)